$3.39 EPS Expected for Cigna Corporation (CI) as of May, 3

Adjust Comment Print

The company's revenue was up 5.9% compared to the same quarter last year. equities research analysts forecast that Cigna will post 12.89 EPS for the current year. Leerink Swann also issued estimates for Cigna's Q2 2018 earnings at $3.60 EPS, Q3 2018 earnings at $3.47 EPS and Q4 2018 earnings at $2.48 EPS. Generally speaking, earnings are expected to grow in coming quarters. Hedge funds and other institutional investors own 88.76% of the company's stock.

Total analysts of 12 have positions in Cigna Corp (NYSE:CI) as follows: 10 rated it a "Buy", 0 with "Sell" and 2 with "Hold". (CI) on Thursday reported first-quarter earnings of $915 million. The health services provider reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.07. Atria Investments LLC now owns 3,580 shares of the health services provider's stock worth $727,000 after buying an additional 314 shares in the last quarter. Cigna had a return on equity of 18.84% and a net margin of 5.38%. CI generated revenue of $10.73 Billion in the same quarter, one year ago. During the same quarter previous year, the business posted $1.87 EPS.

A number of research firms recently commented on CI. On Friday, January 12 the stock of Cigna Corporation (NYSE:CI) earned "Buy" rating by Jefferies. The company rating was maintained by Jefferies on Thursday, February 1. Credit Suisse Group lowered their target price on Cigna from $232.00 to $215.00 and set an "outperform" rating on the stock in a research note on Monday, March 12th. Sanford C. Bernstein assumed coverage on Cigna in a research report on Tuesday, March 13th. RBC Capital Markets has "Buy" rating and $185.0 target. As per Friday, November 3, the company rating was maintained by RBC Capital Markets. The stock has "Buy" rating by Stifel Nicolaus on Tuesday, June 28.

In related news, Director William D. Zollars sold 212 shares of the business's stock in a transaction that occurred on Wednesday, January 10th. The shares were sold at an average price of $205.68, for a total transaction of $43,604.16.

Columbus Hill Capital Management Lp, which manages about $1.68B and $1.56B US Long portfolio, upped its stake in T Mobile Us Inc (NYSE:TMUS) by 344,598 shares to 1.09 million shares, valued at $69.23M in 2017Q4, according to the filing. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Cordani David had sold 36,769 shs worth $7.05M on Friday, March 2. The stock was sold at an average price of $191.84, for a total value of $529,286.56. S Muoio & Company bought 20,000 shares as the company's stock declined 2.24% with the market. The disclosure for this sale can be found here. It turned negative, as 38 investors sold CI shares while 280 reduced holdings. It also reduced its holding in New York Reit Inc (NYSE:NYRT) by 140,000 shares in the quarter, leaving it with 335,300 shares, and cut its stake in News Corp/New (NASDAQ:NWSA). (NYSE:WGL). Glenmede Tru Na owns 298 shares for 0% of their portfolio. Aevitas Wealth Management Inc. bought a new position in shares of Cigna during the 4th quarter worth $162,000. Trillium Asset Limited Liability Co owns 137,009 shares. Finally, Atria Investments LLC lifted its position in Cigna by 9.6% during the 4th quarter. Finally, Bank of Montreal Can lifted its holdings in Cigna by 30.0% in the 4th quarter. The stock has a market cap of $40,759.35, a price-to-earnings ratio of 16.10, a PEG ratio of 1.01 and a beta of 0.61.

Sells 730420 Shares of Gilead Sciences (GILD)
The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website . Savant Cap Ltd Limited Liability Company has 7,335 shares for 0.06% of their portfolio. (NASDAQ: GILD ) for 128,498 shares.


Investors sentiment increased to 1.15 in 2017 Q4. The stock decreased 0.12% or $0.21 during the last trading session, reaching $171.61.

A stock rating usually tells investors how well a stock's market value relates to what analysts think is a fair value for the stock, based on an independent evaluation of the company. The stock is now trading -24.11% away from the 52-week high and separated 10.97% from the 52-week low. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.38. Investors of record on Monday, March 12th were given a $0.04 dividend. The ex-dividend date is Friday, March 9th. This represents a $0.16 dividend on an annualized basis and a yield of 0.09%.

Cigna Corp. (CI) now has a Return on Assets (ROA) value of 3.6 Percent.

Cigna focuses on large and medium-sized corporate healthcare plans and sells worldwide insurance as well as government-backed Medicare plans. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations divisions.The P/E ratio is 19.51.

Comments